Published Dec 3, 2024

Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky

Explore how Alex Oshmyansky, CEO of Cost Plus Drugs, is disrupting the pharmaceutical industry with transparent pricing and innovative AI-driven manufacturing, in partnership with Mark Cuban, challenging traditional pharmacy benefit managers and addressing drug shortages.
Episode Highlights
Masters of Scale logo

Popular Clips

Questions from this episode

Episode Highlights

Related Episodes